TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody

HEFEI, China, June 16, 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific antibody. TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling … Read more

The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

NANJING, China, June 16, 2023 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs” or “Company”) today announces that the phase I/II clinical trial application for LBL-033, an anti-MUC16/CD3 bispecific antibody, for the treatment of ovarian cancer and other malignant tumors, has been approved by the FDA (U.S. Food and Drug Administration). At … Read more

Increasing Cases of Human Papillomavirus Diseases Drive Growth

DUBLIN, June 16, 2023 /PRNewswire/ — The “Human Papillomavirus Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication, By Distribution Channel, By Company and By Region” report has been added to ResearchAndMarkets.com’s offering. The global human papillomavirus vaccine market is anticipated to observe … Read more

EW Group signe un accord avec Sinopharm, la plus grande entreprise de soins de santé de Chine

PETALING JAYA, Malaisie, 16 juin 2023 /PRNewswire/ — European Wellness Biomedical Group (EW Group) a annoncé son partenariat avec HK VJM Ltd (représentant Sinopharm Cloud Health Technology (Guandong) Co. et Sinopharm Traditional Chinese Medicine (Foshan) Co.) et NCL Solutions Sdn Bhd le 15 avril 2023 au One World Hotel. EW Group était représenté par son président, Prof. Dato Sri Dr. Mike Chan, et HK VJM Ltd par M. Guo Liang, tandis que NCL Solutions Sdn Bhd était représenté par Mme Cindy Chong Seau Joon. EW Group fournira son expertise et son expérience … Read more

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH PLAINFIELD, N.J., June 15, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 12, 2023, the company approved non-statutory stock options to purchase an aggregate of 11,260 shares of its common stock and 17,660 restricted stock units (“RSUs”), each representing the right to receive one share of its common stock upon … Read more

Anaemia Drugs Market to Grow Exponentially by 2029 Says Brandessence Market Research

LONDON, June 15, 2023 /PRNewswire/ — Anaemia is a disorder occurrence by the deficiency of red blood cells or decreasing amount of haemoglobin in the blood. It often leads to extreme weakness, fatigue, pale skin and irregular heartbeat, among others. There are several types of drugs used in the treatment of anaemia including Vitamin B12 … Read more

ACROBiosystems Aneuro s’associe à Diagnostic Biochips pour accélérer la découverte de médicaments dans le domaine des neurosciences

BÂLE, Suisse, 15 juin 2023 /PRNewswire/ — ACROBiosystems, par l’intermédiaire d’ACRO Certify et sous sa marque Aneuro, a récemment annoncé le lancement de solutions d’électrophysiologie in vivo pour la recherche en neurosciences avec Diagnostic Biochips. Ces deux entreprises se sont engagées à collaborer ensemble pour accélérer la découverte et la commercialisation de médicaments dans le domaine des … Read more

EW Group Signs with China’s Largest Healthcare, Sinopharm

PETALING JAYA, Malaysia, June 14, 2023 /PRNewswire/ — European Wellness Biomedical Group (EW Group), announced its partnership with HK VJM Ltd (representing Sinopharm Cloud Health Technology (Guandong) Co. and Sinopharm Traditional Chinese Medicine (Foshan) Co.) and NCL Solutions Sdn Bhd on April 15, 2023 at One World Hotel. EW Group represented by Chairman, Prof. Dato’ Sri … Read more

Biomaterials Market size to grow by USD 12,907.35 million from 2022 to 2027, The rising demand for medical implants to drive the market growth

NEW YORK, June 14, 2023 /PRNewswire/ — The biomaterials market size is set to grow by USD 12,907.35 million from 2022 to 2027, progressing at a CAGR of 6% during the forecast period. The rising demand for medical implants is a significant driving factor for the market growth. Biomaterials are used in various medical devices, including implants, to replace or … Read more

Orphan Drugs Market To Reach USD 269210 Million By 2029, Witnessing A CAGR of 9.9%

BANGALORE, India, June 14, 2023 /PRNewswire/ — Orphan Drug Market segmented by Type – Oncology, Gastrointestinal, Pulmonary, Neurology, Hematology, Cardio-vascular, Metabolic Disorders, Endocrinology, Infectious Diseases, Others, by Application – Baby and Child, Teenager, Adult, Other. Global Opportunity Analysis and Industry Forecast 2023-2029. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category. The global … Read more